Regeneron Pharms (REGN): Q2 EPS of $0.90 beats by $0.45. Revenue of $304M (+181.5% Y/Y) beats by...

|About: Regeneron Pharmaceutical... (REGN)|By:, SA News Editor
Regeneron Pharms (REGN): Q2 EPS of $0.90 beats by $0.45. Revenue of $304M (+181.5% Y/Y) beats by $48.02M. (PR)